US Drug Costs Rise At Home, Fall Abroad as Trump Weighs Action

The prices of top prescription drugs from companies such as Amgen Inc., Pfizer Inc., and Merck & Co., increased after launching in the US, even as they fell over time in foreign markets, according to a report from a leading lobbying group for older Americans.

NJ Justices Revive Allergan Product Liability Blindness Suit

A woman who went blind in one eye after receiving an Allergan treatment had her product liability lawsuit against the pharmaceutical giant revived by the New Jersey Supreme Court in a Wednesday ruling strengthening differential diagnosis evidence.

FDA Advances Safety Review of Litigated Food Package Chemicals

The FDA on Wednesday sought public input on its scientific assessment of chemicals used in plastic food packaging that represents the agency’s next step toward evaluating whether substances known as phthalates are still safe for consumers.

Anti-Aging Supplement Company’s Suit Lacks Standing, FDA Says

The Food and Drug Administration urged a federal court to dismiss for lack of standing a bioscience company’s lawsuit accusing the agency of improperly approving a new dietary supplement ingredient.

RxSight Must Litigate Investor Suit Over Eye Lens System Demand

RxSight Inc. must defend against allegations the medical device maker misrepresented the efficacy and patient adoption of its implanted eye lens system designed for use following cataract surgery.

Latest Stories

Kenya, US Are in Ebola Complex Talks After Quarantine Report

Kenya is in talks with the US on Ebola-related health cooperation after media reports that the Trump administration is planning to send Americans exposed to the virus to a quarantine facility in the East African nation being built by the US military.

A Less Chaotic FDA Is a Win for the White House: Editorial

After almost a year of policy disputes, staff turnover and complaints about management, Food and Drug Administration Commissioner Marty Makary resigned under pressure earlier this month. His successor will need to restore order at an agency in turmoil.

Lilly to Launch Drugs Globally Despite Pricing Pressure

Eli Lilly & Co. said it will press ahead with global drug launches despite uncertainty over the Trump administration’s Most-Favored-Nation pricing proposal, which sparked industry concerns that the policy could deter rollouts in lower-priced markets such as Japan.

Beyond Abortion: The Fight Over Fetal Personhood Is Here

When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.

From Across Bloomberg Law

Business & PracticeEnvironment & EnergyEnvironmental, Social & Governance (ESG)The United States Law Week
  • Business & Practice
  • Environment & Energy
  • Environmental, Social & Governance (ESG)
  • The United States Law Week

Covid Vaccine & Personal Data: Does HIPAA Still Matter?

EXPLORE BLOOMBERG LAW

Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: